FDA Adverse Event Malfunction Summary report: N

BD PHOENIX PANEL NMIC-306

MDR report key: 19686666 · Received July 7, 2024

Report

Report Number
1119779-2024-00543
Event Type
Malfunction
Date Received
July 7, 2024
Date of Event
June 2, 2024
Report Date
August 14, 2025
Manufacturer
BECTON DICKINSON & CO. (SPARKS)
Product Code
LON
UDI-DI
00382904492922
PMA / PMN Number
SEE H.11
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY: THIS COMPLAINT IS FOR HIGH MIC MEROPENEM (MEM) AND ERTAPENEM (ETP) WITH CITROBACTER WHEN USING PHOENIX PANEL NMIC-306 (CATALOG NUMBER 449292) BATCH NUMBER 4100303. THE CUSTOMER DID NOT PROVIDE ISOLATES OR PANEL RETURNS BUT PROVIDED PHOENIX GENERATED LAB REPORTS FOR THE INVESTIGATION. THE LAB REPORTS SHOW HIGH MIC MEM AND ETP WITH CITROBACTER WHEN USING THE COMPLAINT BATCH. TO INVESTIGATE, THREE RETENTION PANELS FROM THE COMPLAINT BATCH WERE INOCULATED WITH IN HOUSE ISOLATE CITROBACTER FREUNDII ENF 10852 THEN PLACED IN A PHOENIX M50 FOR MEM AND ETP MIC RESULTS. IN ADDITION, TWO CONTROL PANELS FROM THE SAME MATERIAL BUT DIFFERENT BATCH WERE INOCULATED WITH IN HOUSE ISOLATE CITROBACTER FREUNDII ENF 10852 THEN PLACED IN A PHOENIX M50 FOR MEM AND ETP MIC RESULTS. RESULTS OF THE INVESTIGATION RETURNED ALL PANELS WITH THE EXPECTED MIC FOR MEM AND ETP. THIS COMPLAINT IS NOT CONFIRMED. THE BATCH HISTORY RECORD WAS SATISFACTORY AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. COMPLAINT TRENDING WAS PERFORMED AND NO TRENDS WERE IDENTIFIED ASSOCIATED WITH THIS DEFECT. BD WILL CONTINUE TO MONITOR FOR TRENDS AND TAKE ACTION AS NECESSARY. PLEASE CONTINUE TO COMMUNICATE ANY ADDITIONAL CONCERNS.

Additional Manufacturer Narrative · 0

G5. PMA / 510(K)#: K020322, K022129, K023444, K023634, K023858, K024153, K031530, K031699, K031912, K032299, K032567, K032655, K033362, K033560, K041384, K042932, K052269, K060214, K060217, K060257, K060444, K060447, K061327, K061355, K062207, K062944, K063301, K063486, K063573, K063811, K063824, K071623, K132674, K132909, K151320, K181665, K173252, K190905, K163637, K173523, K033458, AND K123266. H3. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS HAVE BEEN UPDATED: B5. IT WAS REPORTED WHILE USING BD PHOENIX PANEL NMIC-306, A SAMPLE GAVE DIFFERENT RESULTS WHEN RETESTED. THERE WAS NO REPORT OF PATIENT IMPACT. THIS SUPPLEMENTAL MDR IS BEING SUBMITTED AS PART OF A RETROSPECTIVE REVIEW OF RECORDS DATING APRIL 2023¿2025, UNDER CAPA 11910483.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING THE BD PHOENIX PANEL NMIC-306 A PATIENT ISOLATE OF CITROBACTER CLOACAE COMPLEX THAT WAS TESTED 3 TIMES AND GIVING DIFFERENT RESULTS. THE FIRST AND SECOND TIMES ERTAPENEM WAS RESISTANT AND MEROPENEM SENSITIVE. THE RESULT OF THE THIRD TIME TESTING WAS NOT SPECIFIED. THE E-TEST WAS SUSCEPTIBLE. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING THE BD PHOENIX PANEL NMIC-306 A PATIENT ISOLATE OF CITROBACTER CLOACAE COMPLEX THAT WAS TESTED 3 TIMES AND GIVING DIFFERENT RESULTS. THE FIRST AND SECOND TIMES ERTAPENEM WAS RESISTANT AND MEROPENEM SENSITIVE. THE RESULT OF THE THIRD TIME TESTING WAS NOT SPECIFIED. THE E-TEST WAS SUSCEPTIBLE. NO HEALTH IMPACT OR CONSEQUENCE REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING BD PHOENIX PANEL NMIC-306, A SAMPLE GAVE DIFFERENT RESULTS WHEN RETESTED. THERE WAS NO REPORT OF PATIENT IMPACT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
894558 BD PHOENIX PANEL NMIC-306 SYSTEM, TEST, AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY LON BECTON DICKINSON & CO. (SPARKS) 4100303 00382904492922

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown